Marlborough, Mass.-based Boston Scientific entered into a definitive agreement to shell out $230 million for Synergy's M.I. Tech, a medical device manufacturer and distributor, for a 64 percent stake by the end of 2022.
M.I. Tech specializes in devices for endoscopic and urologic procedures, according to the June 15 press release. The deal is subject to customary closing conditions.